N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide

C16H22N4O2 — CID 131891746

IUPACN-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide
SMILESCC(O)c1nc2ccc(NC(=O)CC3CCNCC3)cc2[nH]1
InChIInChI=1S/C16H22N4O2/c1-10(21)16-19-13-3-2-12(9-14(13)20-16)18-15(22)8-11-4-6-17-7-5-11/h2-3,9-11,17,21H,4-8H2,1H3,(H,18,22)(H,19,20)
InChIKeyWAWHVRJRUSJBOI-UHFFFAOYSA-N
MW302.38 g/mol
LogP1.94
Rot. Bonds4

About N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide

N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide (PubChem CID 131891746) has the molecular formula C16H22N4O2 and a molecular weight of 302.38 g/mol. Its IUPAC name is N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide.

Molecular Properties

Compound NameN-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide
PubChem CID131891746
Molecular FormulaC16H22N4O2
Molecular Weight302.38 g/mol
Exact Mass302.17
IUPAC NameN-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide
SMILESCC(O)c1nc2ccc(NC(=O)CC3CCNCC3)cc2[nH]1
InChIInChI=1S/C16H22N4O2/c1-10(21)16-19-13-3-2-12(9-14(13)20-16)18-15(22)8-11-4-6-17-7-5-11/h2-3,9-11,17,21H,4-8H2,1H3,(H,18,22)(H,19,20)
InChIKeyWAWHVRJRUSJBOI-UHFFFAOYSA-N
XLogP1.94
TPSA90.04 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500302.38
LogP ≤ 51.94
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Analyze N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyano-N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]acetamide
CID 168520800
2-(3,4-dimethylphenyl)-N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]acetamide
CID 131918595
2-(1,3-benzodioxol-5-yl)-N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]acetamide
CID 131936069
2-cyclohexyl-N-(2-phenyl-3H-benzimidazol-5-yl)acetamide
CID 163397662
N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-3-pyrazol-1-ylpropanamide
CID 131908353
[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]thiourea
CID 169356684
N-(3,4-dichlorophenyl)-2-piperidin-4-ylacetamide;hydrochloride
CID 119670897
N-(3H-benzimidazol-5-yl)-2-pyrrolidin-3-ylacetamide
CID 115160286
N-(2-methyl-1,3-benzoxazol-5-yl)-2-piperidin-4-ylacetamide;dihydrochloride
CID 119833735
N-(3-fluoro-4-methylphenyl)-2-piperidin-4-ylacetamide
CID 24690499
3,4-difluoro-N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]benzamide
CID 131952585
1-(2-ethoxyacetyl)-N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]piperidine-4-carboxamide
CID 131922240

Frequently Asked Questions

What is the IUPAC name of N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide?
The IUPAC name of N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide (CID 131891746) is N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide.
What is the SMILES notation for N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide?
The canonical SMILES for N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide is CC(O)c1nc2ccc(NC(=O)CC3CCNCC3)cc2[nH]1.
What is the InChIKey of N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide?
The InChIKey is WAWHVRJRUSJBOI-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H22N4O2/c1-10(21)16-19-13-3-2-12(9-14(13)20-16)18-15(22)8-11-4-6-17-7-5-11/h2-3,9-11,17,21H,4-8H2,1H3,(H,18,22)(H,19,20).
What are the key properties of N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide?
N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide has a molecular weight of 302.38 g/mol, XLogP of 1.94, 4 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(1-hydroxyethyl)-3H-benzimidazol-5-yl]-2-piperidin-4-ylacetamide is sourced from PubChem (CID 131891746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).